Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Clinical trial NCT00021047 · COMPLETED

Trial details

NCT number: NCT00021047
Sponsor: National Institutes of Health Clinical Center (CC)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Extrahepatic Bile Duct Cancer Gastric Cancer Head and Neck Cancer Liver Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2001-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.